The use of human amniotic fluid stem cells as an adjunct to promote pulmonary development in a rabbit model for congenital diaphragmatic hernia
The use of human amniotic fluid stem cells as an adjunct to promote pulmonary development in a rabbit model for congenital diaphragmatic hernia
复制标题
DOI:
10.1002/pd.4621
复制
发表时间:
2015-09-01
影响因子:
3
通讯作者:
Deprest, Jan
中科院分区:
文献类型:
--
作者:
DeKoninck, Philip;Toelen, Jaan;Deprest, Jan
ObjectiveThis study aimed to evaluate the potential benefit of intra-tracheal injection of human amniotic fluid stem cells (hAFSC) on pulmonary development combined with TO in a rabbit model for CDH.MethodsIn time-mated pregnant does a left diaphragmatic defect was created at d23 (term=31). At d28, previously operated fetuses were assigned to either TO and injection with 70L of phosphate buffered saline (PBS) or 1.0x10(6) c-Kit positive hAFSC expressing LacZ or were left untouched (CDH). Harvesting was done at d31 to obtain their lung-to-body weight ratio (LBWR), airway and vascular lung morphometry, X-gal staining and immunohistochemistry for Ki67 and surfactant protein-B (SP-B).ResultsCDH-induced pulmonary hypoplasia is countered by TO+PBS, this reverses LBWR, mean terminal bronchiole density (MTBD) and medial thickness to normal. The additional injection of hAFSC decreases MTBD and results in a non-significant decrease in muscularization of intra-acinary vessels. There were no inflammatory changes and LacZ positive hAFSC were dispersed throughout the lung parenchyma 4days after injection.ConclusionHAFSC exert an additional effect on TO leading to a decrease in MTBD, a measure of alveolar number surrounding the terminal bronchioles, without signs of toxicity. (c) 2015 John Wiley & Sons, Ltd.